The John Merck Fund has a long history of funding efforts to benefit human health and environmental sustainability in New England and beyond. You can navigate our previous grantmaking efforts below by typing in a keyword, or filtering by program, topic or year.
| Date | Description | Program Area | Focus | Amount |
|---|---|---|---|---|
| 03/2019 |
University of Wisconsin-Madison Waisman CenterTo establish high-quality stem cell lines from people with Fragile X for use in future research. Two-year grant 2019-2020. |
Developmental Disabilities |
Translational Research Program |
$245,000 |
| 09/2017 |
Stanford UniversityTo support research by Philippe Mourrain, PhD, on “Synaptic System Characterization and Pharmacological Normalization of Fragile X Syndrome.” Three-year grant 2017-2020. |
Developmental Disabilities |
Translational Research Program |
$750,000 |
| 04/2016 |
University of California, Los AngelesTo support research in Fragile X syndrome by Principal Investigator Carlos Portera-Cailliau. Four-year grant 2016-2020. |
Developmental Disabilities |
Translational Research Program |
$1,000,000 |
| 12/2015 |
Stanford UniversityTo conduct research by Scott Hall on Fragile X syndrome. Four-year grant 2015-2019. |
Developmental Disabilities |
Translational Research Program |
$1,000,000 |
| 02/2015 |
University of Wisconsin-Madison Waisman CenterTo support research about Fragile X by Principal Investigators Xinyu Zhao and Anita Bhattacharyya. Three-year grant 2015-2018. |
Developmental Disabilities |
Translational Research Program |
$750,000 |
| 07/2014 |
Boston Children’s HospitalTo conduct research in Down syndrome. |
Developmental Disabilities |
Translational Research Program |
$150,000 |
| 12/2013 |
University of Wisconsin-Madison Waisman CenterTo conduct research into identifying reactivation reagents in a high throughput unbiased screen using human Fragile X patient-derived neural cells, to correct the root cause of Fragile X. |
Developmental Disabilities |
Translational Research Program |
$100,000 |
| 12/2013 |
Vanderbilt UniversityTo conduct a randomized controlled trial of an early communication intervention with children with Down syndrome. Four-year grant 2014-2018. |
Developmental Disabilities |
Translational Research Program |
$1,000,000 |
| 12/2012 |
Cincinnati Children’s HospitalTo conduct a Phase II placebo-controlled proof of concept study of acamprosate in 48 youth with Fragile X Syndrome. Four-year grant 2012-2016. |
Developmental Disabilities |
Translational Research Program |
$1,000,000 |
| 12/2012 |
University of California, DavisTo evaluate the efficacy of Cogmed, a cognitive training program that enhances working memory and executive function, in individuals with Fragile X Syndrome, in a research project by David Hessl, PhD. Four-year grant 2012-2016. |
Developmental Disabilities |
Translational Research Program |
$1,000,000 |